Evidence map›Paper›PMID 42369249›Full record

ArticleClinical neurophysiology practice2026

Ultrasonographic cross-sectional area in classifying ulnar neuropathy at the elbow.

Nathan J Savage, John S McKell

Abstract read
In one paragraph

Article in Clinical neurophysiology practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nathan J SavageDepartment of Physical Therapy, High Point University, Congdon Hall 4152, One University Parkway, High Point, NC 27268, USA.
John S McKellDepartment of Physical Therapy, McKell Therapy Group, LLC, Orem UT84097, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Ulnar neuropathy at the elbow (UNE) is a common entrapment neuropathy for which electrodiagnostic (EDX) testing is frequently used. Although multi-tiered electrophysiologic severity classifications exist, the extent to which ultrasound imaging (USI)-derived ulnar nerve cross-sectional area (CSA) provides incremental discrimination across severity categories and informs probabilistic clinical decision-making remains unclear. Methods: This retrospective analysis of prospectively collected cross-sectional data included 299 elbows from 262 patients referred for EDX testing with clinical suspicion of UNE. Elbows were classified using two multi-tiered electrophysiologic systems (Padua and Zeidman) and consolidated binary categorizations (Negative vs UNE). USI-derived ulnar nerve CSA was evaluated using receiver operating characteristic analyses and likelihood ratios to estimate post-test probability shifts across severity categories and binary classifications, accounting for clustering of bilateral elbows. Results: CSA demonstrated limited incremental discrimination between adjacent categories within multi-tiered electrophysiologic classifications, resulting in modest post-test probability shifts. In contrast, binary categorizations showed stronger discriminative performance. CSA values <6 mm Conclusions: USI-derived ulnar nerve CSA does not reliably discriminate between adjacent electrophysiologic severity categories of UNE. A simplified binary interpretive framework using CSA thresholds may offer greater clinical utility. Significance: These findings support probabilistic, rather than severity-grading, use of USI when evaluating suspected UNE in patients referred for EDX testing.

Indexed as

Cross-sectional areaDiscriminative performanceElectrodiagnosisElectromyographyNerve conductionSonographyUlnar neuropathy

Identifiers

PMID42369249
PMCPMC13293735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.